Abstract

In this brief the innovative realm of artificial cell membranes as bioinformation hubs, specifically focusing on their role in creating therapeutic networks, is proposed. The integration of advanced nanotechnologies, bioinformatics, cheminformatics, and medical informatics has paved the way for the development of in silico tools that facilitate the simulation of interactions and mechanisms of toxicity in therapeutic products, particularly in drug delivery nanosystems. Various specialized cloud platforms incorporate libraries of diverse nanomaterials with comprehensive morphological and biological data, enabling correlation with potential adverse effects. Such tools prove invaluable in guiding the pharmaceutical industry in the development of innovative therapeutical formulations and aiding regulatory agencies in evaluating decision-making nanoplatforms. Finally, in this opinion-article we support the idea the cell membranes could be considered as bioinformation hubs and artificial pharmaceutical nanoplatforms.

Keywords:Bioinformatics; Biostatistics; Complex systems; Artificial bio-networks; Liposomes; Lipid nanoparticles; Precision medicine